Fund Companies Rights Offerings Managed Distributions Leveraged Funds IPOs Asset Classes CEF Advisors

My Fund Comparison
Initilizing list...

Tekla Healthcare Investors  as of 11/18/2019

NYSE / HQH Asset Class:  Sector Equity Funds 1 YR Lipper Avg:  10.46%

Growth of $10K

Avg Annual Total Return %
  10 YR 5 YR 1 YR YTD
Market Return 14.93% -0.27% 6.58% 18.78%
Lipper Pct. Rank 56 86 67 67
NAV Return 13.24% 2.06% 7.97% 16.44%
Lipper Pct. Rank 45 77 55 45

NAV $22.55 Market Price $19.95
Net Change -$0.03 Market Change -$0.04
Premium/Discount -11.53%
1 YR NAV Return 7.969%
1 YR NAV Rank 55
12-Mo Yield as of 10/31/2019 Yield Def
Income Only Yield 0.00%
Distribution Yield (Market) 9.96%
Most Recent Income Dividend $0.470
Ex-Div Date 8/25/2016
Most Recent Cap Gain Dividend $0.450
Ex-Div Date 8/27/2019
Dividend Frequency Quarterly
YTD Dividends --
YTD Capital Gains $1.310
Inception Date 4/23/1987
Fund Advisor Tekla Capital Management LLC
Manager & Tenure Team Managed
Phone 800-451-2597
Total Net Assets (mil) as of 10/31/2019 $931.5
% Leveraged Assets as of 9/30/2018 --
Portfolio Turnover 46.00%
Mgmt Fees 0.906%
Expense Ratio 1.080%
Fund Objective
The Fund seeks long-term capital appreciation by investing primarily in securities of companies in the health services and medical technology (health care) industries ("Health care Companies").
Top Holdings (as of 6/30/2019)
Celgene Corp ORD 7.74%
Amgen Inc ORD 7.01%
Gilead Sciences Inc ORD 6.63%
Vertex Pharmaceuticals Inc ORD 4.97%
Illumina Inc ORD 4.30%
Biogen Inc ORD 3.10%
Alexion Pharmaceuticals Inc ORD 3.04%
Regeneron Pharmaceuticals Inc ORD 2.86%
Incyte Corp ORD 2.50%
Merck & Co Inc ORD 1.75%
Top Sectors (as of 6/30/2019)
Health Care 91.00%
Non Classified Equity 5.38%
Consumer Services 0.89%
Industrials 0.63%


Aberdeen Closed-End TV

Asset TV — CEF Channel

CEF Connect

Cohen & Steers CEFs Knowledge Center

Harvest — CEFA Channel

Legg Mason CEFs

Seeking Alpha — CEFA Channel

SySys Logo

Lipper Logo
Powered by a SySys data & content management system.

© Thomson Reuters 2019. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.